2016. ISPOR European Congress – Cost-effectiveness of apremilast in moderate to severe psoriasis in Canada

Cawston H, Damera V, Ektare V, Shear NH, Tencer T, Liu FF. Cost-effectiveness of apremilast in moderate to severe psoriasis in Canada. Value Health. 2016 Nov;19(7):A587. Presented at: ISPOR 19th Annual European Congress; November 1, 2016; Vienna Austria.